Abstract:Nanotechnology has ushered in significant advancements in drug design, revolutionizing the prevention, diagnosis, and treatment of various diseases. The strategic utilization of nanotechnology to enhance drug loading, delivery, and release has garnered increasing attention, leveraging the enhanced physical and chemical properties offered by these systems. Polyamidoamine (PAMAM) dendrimers have been pivotal in drug delivery, yet there is room for further enhancement. In this study, we conjugated PAMAM dendrimers with chitosan (CS) to augment cellular internalization in tumor cells. Specifically, doxorubicin (DOX) was initially loaded into PAMAM dendrimers to form DOX-loaded PAMAM (DOX@PAMAM) complexes via intermolecular forces. Subsequently, CS was linked onto the DOX-loaded PAMAM dendrimers to yield CS-conjugated PAMAM loaded with DOX (DOX@CS@PAMAM) through glutaraldehyde crosslinking via the Schiff base reaction. The resultant DOX@CS@PAMAM complexes were comprehensively characterized using Fourier-transform infrared (FTIR) spectroscopy, transmission electron microscopy (TEM), and dynamic light scattering (DLS). Notably, while the drug release profile of DOX@CS@PAMAM in acidic environments was inferior to that of DOX@PAMAM, DOX@CS@PAMAM demonstrated effective acid-responsive drug release, with a cumulative release of 70% within 25 h attributed to the imine linkage. Most importantly, DOX@CS@PAMAM exhibited significant selective cellular internalization rates and antitumor efficacy compared to DOX@PAMAM, as validated through cell viability assays, fluorescence imaging, and flow cytometry analysis. In summary, DOX@CS@PAMAM demonstrated superior antitumor effects compared to unconjugated PAMAM dendrimers, thereby broadening the scope of dendrimer-based nanomedicines with enhanced therapeutic efficacy and promising applications in cancer therapy.

Dendrimers as potential drug carriers. Part II. Prolonged delivery of ketoprofen by in vitro and in vivo studies.

Preparation and in vitro characterization of pluronic-attached polyamidoamine dendrimers for drug delivery.

Dendrimers As Potential Drug Carriers. Part I. Solubilization of Non-Steroidal Anti-Inflammatory Drugs in the Presence of Polyamidoamine Dendrimers

Transdermal delivery of nonsteroidal anti-inflammatory drugs mediated by polyamidoamine (PAMAM) dendrimers.

Polyamidoamine dendrimers used as solubility enhancers of ketoprofen.

Mesoporous Silica Particles As a Multifunctional Delivery System for Pain Relief in Experimental Neuropathy.

Potential of Poly(amidoamine) Dendrimers As Drug Carriers of Camptothecin Based on Encapsulation Studies.

Dendrimers As Drug Carriers: Applications in Different Routes of Drug Administration

Evaluation of phenylbutazone and poly(amidoamine) dendrimers interactions by a combination of solubility, 2D-NOESY NMR, and isothermal titration calorimetry studies.

Pharmaceutical applications of dendrimers: promising nanocarriers for drug delivery.

Synthesis of PEGylated PAMAM Dendrimer As a Drug Carrier

The Drug Loading Behavior of PAMAM Dendrimer: Insights from Experimental and Simulation Study

Enhanced Oral Bioavailability of Doxorubicin in A Dendrimer Drug Delivery System

PEGylated PAMAM Dendrimers As a Potential Drug Delivery Carrier:In Vitroandin Vivocomparative Evaluation of Covalently Conjugated Drug and Noncovalent Drug Inclusion Complex

Polyamidoamine (PAMAM) dendrimers as biocompatible carriers of quinolone antimicrobials: an in vitro study.

Synthesis of Degradable Bifunctional Dendritic Polymers As Versatile Drug Carriers

Poly(amidoamine) Dendronized Hollow Fiber Membranes: Synthesis, Characterization, and Preliminary Applications As Drug Delivery Devices

Toxicity of polyamidoamine dendrimers in vivo

Indomethacin-loaded Polymeric Nanocarriers Based on Amphiphilic Polyphosphazenes with Poly (N-Isopropylacrylamide) and Ethyl Tryptophan As Side Groups: Preparation, in Vitro and in Vivo Evaluation.

Evaluation of Polyamidoamine (PAMAM) Dendrimers As Drug Carriers of Anti-Bacterial Drugs Using Sulfamethoxazole (SMZ) As a Model Drug.

Selective Cellular Uptake and Druggability Efficacy through Functionalized Chitosan-Conjugated Polyamidoamine (PAMAM) Dendrimers